Explore & Compare .abbvie Domain Prices

New registration prices are for the initial year, after which Renewal prices apply. However, you are always free to move to another provider. This is often a good option as Transfer prices may be cheaper than Renewal

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Registrar
New
Renew
Transfer
No items found.
Advertisement

Why a .abbvie Domain? Benefits, Registration, Tips, and Applications

What is .abbvie?

The .abbvie domain extension is a branded TLD specifically created for AbbVie, a global biopharmaceutical company. This domain provides a secure and recognizable online space for AbbVie’s products, research, and corporate information.

A little background

Introduced in the mid-2010s, the .abbvie TLD was part of ICANN’s initiative to expand gTLDs. AbbVie secured this domain to strengthen its online presence and protect its brand identity.

Can I register a .abbvie domain name?

The .abbvie domain is not available for public registration. It is controlled by AbbVie, ensuring only the corporation and its authorized entities use this TLD.

Potential applications

  • Corporate Websites: Official sites for AbbVie’s global operations and business units.
  • Product Information: Pages detailing AbbVie’s biopharmaceutical products and research.
  • Patient Resources: Platforms offering support and information for patients and healthcare providers.
  • Investor Relations: Sites providing financial reports, investor updates, and corporate news.

Short and sweet

The .abbvie domain extension provides a secure and trusted online space for AbbVie. Exclusively used by AbbVie, this TLD ensures that any .abbvie website is directly affiliated with the company, enhancing its brand visibility and protecting its digital identity.

Fun .abbvie facts
  • Humira Success: AbbVie's drug Humira is one of the best-selling prescription drugs in history, treating conditions like arthritis, Crohn's disease, and psoriasis.
  • Focus on Research: AbbVie invests heavily in research and development, with around 20% of its revenue dedicated to discovering and advancing new treatments.

Advertisement